Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | RECQL | P46063 | 3/20 | 0.59 |
| ▸ | BLM | P54132 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.59 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL342454 | 1.00 | FTO (0.59) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL5668768 | 0.99 | FTO (0.58) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL12496351 | 0.89 | FTO (0.59) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL2360878 | 0.86 | FTO (0.63) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL486832 | 0.82 | HPGD (0.64) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL4304748 | 0.81 | HPGD (0.63) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL1263259 | 0.81 | HPGD (0.63) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL293820 | 0.81 | FTO (0.59) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL1908131 | 0.81 | HPGD (0.63) | FTOMEN1KMT2AMAPTRECQL | |
| SCHEMBL11220390 | 0.81 | FTO (0.50) | FTOMEN1KMT2AMAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195400-A1 | PIGMENT DISPERSIONS WITH HYDROPHOBIC POLYMER | L'OREAL (FR) | 2025-06-19 | — | — | US | disclosed |
| EP-4556075-A1 | MARKER COMPOSITION FOR SKIN, AND APPLICATION TOOL FOR SAME | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2025-05-21 | — | — | EP | disclosed |
| US-20240141174-A1 | SPRAY-DRIED DYE COMPOSITIONS, PROCESS FOR THE PRODUCTION AND USE THEREOF | SENSIENT IMAGING TECH GMBH (DE) | 2024-05-02 | — | — | US | disclosed |
| CN-113498429-B | Aqueous pigment ink | 施万-斯特比洛化妆品公司 | 2024-03-08 | — | — | CN | disclosed |
| EP-4106814-A1 | TREATMENT OF SOLID CANCEROUS TUMORS BY ORAL ADMINISTRATION OF A HALOGENATED XANTHENE | Provectus Pharmatech, Inc. (US) | 2022-12-28 | — | — | EP | disclosed |
| US-20220372298-A1 | SPRAY-DRIED DYE COMPOSITIONS, PROCESS FOR THE PRODUCTION AND USE THEREOF | SENSIENT IMAGING TECH GMBH (DE) | 2022-11-24 | — | — | US | disclosed |
| US-11229584-B2 | Pigment dispersion liquid for cosmetics, and aqueous liquid cosmetic using same | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195400-A1 | PIGMENT DISPERSIONS WITH HYDROPHOBIC POLYMER | TYR, MC1R, ALAD | FTO 887/4885MEN1 320/4885KMT2A 2780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.